Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vikas Pai"'
Autor:
H. R. Salkar, Rajesh Khyalappa, Mahendra Parmar, Anil Pareek, Manish Agarwal, R. Legha, Urman Dhruv, Navneet Agrawal, Nitin Chandurkar, N. K. Thulaseedharan, Vikas Pai, Usha Sriram, S. Mathur, Subhash Saxena, Sangeeta Pednekar
Publikováno v:
Current Medical Research and Opinion. 31:2105-2117
To evaluate the efficacy and safety of atorvastatin + hydroxychloroquine fixed-dose combination tablets in comparison with atorvastatin alone in treatment of dyslipidemia.This double-blind, randomized, out-patient study was conducted in 328 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1316bbb7bc3c2ec4d22f28ddfa195ef5
https://doi.org/10.1185/03007995.2015.1087989
https://doi.org/10.1185/03007995.2015.1087989
Autor:
Satinath Mukhopadhyay, Patel Pankaj Ramanbhai, Vikas Pai, Anil Bhansali, Shashank R Joshi, Rajendrakumar H. Jani, V. Shankar, Gambhire Dhiraj, Dinesh Kamath, A Paneerselvam
Publikováno v:
Journal of Diabetes Science and Technology
Background: Dual PPARα/γ can improve both metabolic effects and minimized the side effects caused by either PPARα or PPARγ agonist. The PRESS V study was aimed to evaluate the safety, tolerability, and efficacy of saroglitazar 2 mg and 4 mg capsu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ccd9d08e10d6dd8bfb53d745484db6
https://doi.org/10.1177/1932296813518680
https://doi.org/10.1177/1932296813518680
Autor:
Anil Bhansali, Pramod Jha, Rajendrakumar H. Jani, Vikas Pai, Shashank R Joshi, Satinath Mukhopadhyay, Gunjan Jariwala
Publikováno v:
Diabetes technologytherapeutics. 16(2)
Dyslipidemia due to diabetes is characterized by hypertriglyceridemia and reduced levels of high-density lipoprotein cholesterol (HDL-C) and elevated or normal levels of low-density lipoprotein cholesterol (LDL-C) in type 2 diabetes mellitus (T2DM).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e354f4aac121841174e4e7e454b930d6
https://pubmed.ncbi.nlm.nih.gov/24138536
https://pubmed.ncbi.nlm.nih.gov/24138536
Autor:
Vikas, Pai, Nitin, Pai
Publikováno v:
Journal of the Indian Medical Association. 105(8)
Chirality is a ubiquitous natural phenomenon resulting because of a differential spatial orientation of molecules around its chiral centre. This leads to the existence of two or more spatially dissimilar forms, known as stereoisomers or enantiomers,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ff924b36c2a630efbb9d53dda974e26
https://pubmed.ncbi.nlm.nih.gov/18236913
https://pubmed.ncbi.nlm.nih.gov/18236913
Autor:
Naresh Trehan, Vikas Pai, Sameer Dani, Siddharth Shah, Rajeev Gupta, Manish Bansal, Ravi R Kasliwal, Abraham Oomman
Publikováno v:
Journal of the American College of Cardiology. 65:A1480
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d03bf2dfd6db58e76417c805f017fe
https://doi.org/10.1016/s0735-1097(15)61480-2
https://doi.org/10.1016/s0735-1097(15)61480-2
Autor:
Abraham Koshy, Padaki Nagaraja Rao, Nitin Vikas Pai, Narayanan Premaletha, Krishnasamy Narayanasamy, Manoj Agarwal, Joy Varghese, Jacob Philip, Samir Mohindra, Ashoknanda Konar, Hasmukh B Vora
Publikováno v:
World Journal of Hepatology. 6:520
AIM: To study the safety and efficacy of pegylated interferon alfa-2b, indigenously developed in India, plus ribavirin in treatment of hepatitis C virus (HCV). METHODS: One-hundred HCV patients were enrolled in an open-label, multicenter trial. Patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9e56de27252004b03dcfb800ba32bdd
https://doi.org/10.4254/wjh.v6.i7.520
https://doi.org/10.4254/wjh.v6.i7.520
Autor:
Naresh Trehan, Sakthivel Sivam, Guru Mallapa Prasad, Abraham Oomman, Ravi R Kasliwal, Sunil Singhvi, Siddharth Shah, Rajeev Gupta, Manish Bansal, Vikas Pai, Sameer Dani, Jitendra Patel
Publikováno v:
Nutrition. (7-8):767-776
ObjectiveEvidence suggests prolonged exposure to lower levels of low-density lipoprotein cholesterol (LDL-C), starting at a younger age, substantially lowers cardiovascular (CV) risk. Accordingly, the CV pandemic affecting younger population in low-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::641920343983edc26467e9af1b163518